This is a biotech company to watch closely as the future of medicine changes.

This is a biotech company to watch closely as the future of medicine changes. The company's products have the potential to save millions of lives while building market capitalization growth for it in the process! It's no secret that the human body has an amazing ability to heal itself. You may have heard the term regenerative medicine before. It's basically where the body uses its own systems to rebuild tissues and organs. With its potential to heal, regenerative medicine has become a VERY hot topic and is expected to revolutionize healthcare. The market for regenerative medicine is expected to experience significant growth over the next few years. It comes as no surprise that some of the biggest companies in healthcare are working hard to make advances in this vital space. This includes major players like Amgen, Sanofi, and Gilead Sciences. There's another player going undetected that could soon hit the spotlight for its part in the regenerative medicine boom! Trading at just a few dollars, (OTC:BSEM) is providing a vital service to the human population and this could mean economic value to shareholders at the same time! How? By manufacturing allografts that come from the human placenta. This is essentially a tissue transplant product from the placenta. In the space of skin substitutes, it is like xenografts or grafts from an animal. The increased adoption of perinatal tissues has allowed for its significant penetration into the multibillion-dollar soft tissue repair market, which is expected to reach around $8.6B by 2030! As more doctors become familiar with the company's unique technology, it could open doors to many revenue opportunities and its growth on Wall Street. See how at these levels this little-known biotech company could be at a value!

---

This message is a PAID ADVERTISEMENT for BioStem Technologies Inc. (OTC: BSEM) from Sideways Frequency. StockEarnings, Inc receives a fixed fee for each subscriber that clicks on a link in this email, totaling up to $1,000. Other than the compensation received for this advertisement sent to subscribers, StockEarnings and its principals are not affiliated with either BioStem Technologies Inc. (OTC: BSEM) or Sideways Frequency. StockEarnings and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither StockEarnings nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from StockEarnings to buy or sell any security. StockEarnings has not evaluated the accuracy of any claims made in this advertisement. StockEarnings recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding BioStem Technologies Inc. (OTC: BSEM) on Huge Alerts website for additional information about the relationship between Sideways Frequency and BioStem Technologies Inc. (OTC: BSEM).

Your privacy is very important to us, if you wish to be excluded from future notices, do not reply to this message. Instead, please click Unsubscribe.

StockEarnings, Inc
33 SE 4th St, Suite 100, Boca Raton, FL 33432 USA
W: 877.6.STOCKS
StockEarnings.com